Empresa Mateon Therapeutics, Inc. Other OTC
Acciones
MATN
US57667K1097
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22/04/19 |
Director of Finance/CFO | 57 | 01/07/19 | |
Seymour H. Fein
CTO | Chief Tech/Sci/R&D Officer | 75 | 06/01/20 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/05/20 |
Saran Saund
PRN | Corporate Officer/Principal | 66 | 01/11/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven King
BRD | Director/Board Member | 59 | 11/05/20 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/05/20 |
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22/04/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 399 684 128 | 180 543 314 ( 45,17 %) | 0 | 45,17 % |
Información de la empresa
![Dirección Mateon Therapeutics, Inc.(MATN)](https://cdn.zonebourse.com/static/address/32411254.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+18,15 % | 124 mil M | |
+18,02 % | 112 mil M | |
-12,75 % | 22,22 mil M | |
+5,07 % | 22,94 mil M | |
-39,94 % | 16,87 mil M | |
-9,86 % | 17,02 mil M | |
-14,97 % | 16,88 mil M | |
+2,80 % | 13,63 mil M | |
+27,39 % | 11,61 mil M |